1. Home
  2. VIR vs KFRC Comparison

VIR vs KFRC Comparison

Compare VIR & KFRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • KFRC
  • Stock Information
  • Founded
  • VIR 2016
  • KFRC 1962
  • Country
  • VIR United States
  • KFRC United States
  • Employees
  • VIR N/A
  • KFRC N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • KFRC Professional Services
  • Sector
  • VIR Health Care
  • KFRC Consumer Discretionary
  • Exchange
  • VIR Nasdaq
  • KFRC Nasdaq
  • Market Cap
  • VIR 706.4M
  • KFRC 592.8M
  • IPO Year
  • VIR 2019
  • KFRC 1995
  • Fundamental
  • Price
  • VIR $5.08
  • KFRC $30.55
  • Analyst Decision
  • VIR Strong Buy
  • KFRC Buy
  • Analyst Count
  • VIR 10
  • KFRC 3
  • Target Price
  • VIR $26.80
  • KFRC $52.33
  • AVG Volume (30 Days)
  • VIR 1.5M
  • KFRC 275.7K
  • Earning Date
  • VIR 10-30-2025
  • KFRC 10-27-2025
  • Dividend Yield
  • VIR N/A
  • KFRC 4.98%
  • EPS Growth
  • VIR N/A
  • KFRC N/A
  • EPS
  • VIR N/A
  • KFRC 2.39
  • Revenue
  • VIR $19,000,000.00
  • KFRC $1,361,445,000.00
  • Revenue This Year
  • VIR N/A
  • KFRC N/A
  • Revenue Next Year
  • VIR $9.65
  • KFRC $0.75
  • P/E Ratio
  • VIR N/A
  • KFRC $13.12
  • Revenue Growth
  • VIR N/A
  • KFRC N/A
  • 52 Week Low
  • VIR $4.16
  • KFRC $29.33
  • 52 Week High
  • VIR $14.45
  • KFRC $64.07
  • Technical
  • Relative Strength Index (RSI)
  • VIR 51.83
  • KFRC 39.89
  • Support Level
  • VIR $5.04
  • KFRC $29.33
  • Resistance Level
  • VIR $5.39
  • KFRC $31.36
  • Average True Range (ATR)
  • VIR 0.34
  • KFRC 1.15
  • MACD
  • VIR 0.05
  • KFRC 0.15
  • Stochastic Oscillator
  • VIR 49.20
  • KFRC 29.85

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About KFRC Kforce Inc.

Kforce Inc is a solutions firm specializing in technology, finance and accounting, and other professional staffing services. The company operates two business segments: 1) In technology segment it provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. 2) In FA segment company offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting business and cost analysis; and taxation and treasury. The majority of revenue is earned through the technology segment.

Share on Social Networks: